Riggs Asset Managment Co. Inc. Crinetics Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $358 Million
- Q3 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 34 shares of CRNX stock, worth $1,314. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$1,314
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
243Shares Held
80.1MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$243 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$241 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$227 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$191 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$172 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.08B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...